QTTB
Price
$1.85
Change
+$0.04 (+2.21%)
Updated
Sep 16, 12:37 PM (EDT)
Capitalization
22.08M
STOK
Price
$23.43
Change
+$0.03 (+0.13%)
Updated
Sep 16, 04:40 PM (EDT)
Capitalization
1.28B
56 days until earnings call
Interact to see
Advertisement

QTTB vs STOK

Header iconQTTB vs STOK Comparison
Open Charts QTTB vs STOKBanner chart's image
Q32 Bio
Price$1.85
Change+$0.04 (+2.21%)
Volume$300
Capitalization22.08M
Stoke Therapeutics
Price$23.43
Change+$0.03 (+0.13%)
Volume$926
Capitalization1.28B
QTTB vs STOK Comparison Chart in %
Loading...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QTTB vs. STOK commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QTTB is a StrongBuy and STOK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (QTTB: $1.81 vs. STOK: $23.40)
Brand notoriety: QTTB and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QTTB: 16% vs. STOK: 93%
Market capitalization -- QTTB: $22.08M vs. STOK: $1.28B
QTTB [@Biotechnology] is valued at $22.08M. STOK’s [@Biotechnology] market capitalization is $1.28B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QTTB’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 1 green FA rating(s).

  • QTTB’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 1 green, 4 red.
According to our system of comparison, STOK is a better buy in the long-term than QTTB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QTTB’s TA Score shows that 3 TA indicator(s) are bullish while STOK’s TA Score has 4 bullish TA indicator(s).

  • QTTB’s TA Score: 3 bullish, 5 bearish.
  • STOK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, STOK is a better buy in the short-term than QTTB.

Price Growth

QTTB (@Biotechnology) experienced а +3.43% price change this week, while STOK (@Biotechnology) price change was +6.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.29%. For the same industry, the average monthly price growth was +6.86%, and the average quarterly price growth was +34.07%.

Reported Earning Dates

STOK is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+3.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($1.28B) has a higher market cap than QTTB($22.1M). STOK YTD gains are higher at: 112.149 vs. QTTB (-47.384). STOK has higher annual earnings (EBITDA): 42.3M vs. QTTB (-33.17M). STOK has more cash in the bank: 248M vs. QTTB (54.8M). STOK has less debt than QTTB: STOK (2.3M) vs QTTB (18.7M). STOK has higher revenues than QTTB: STOK (200M) vs QTTB (0).
QTTBSTOKQTTB / STOK
Capitalization22.1M1.28B2%
EBITDA-33.17M42.3M-78%
Gain YTD-47.384112.149-42%
P/E RatioN/A26.97-
Revenue0200M-
Total Cash54.8M248M22%
Total Debt18.7M2.3M814%
FUNDAMENTALS RATINGS
QTTB vs STOK: Fundamental Ratings
QTTB
STOK
OUTLOOK RATING
1..100
2220
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10046
PRICE GROWTH RATING
1..100
6335
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTTB's Valuation (41) in the null industry is in the same range as STOK (62). This means that QTTB’s stock grew similarly to STOK’s over the last 12 months.

QTTB's Profit vs Risk Rating (100) in the null industry is in the same range as STOK (100). This means that QTTB’s stock grew similarly to STOK’s over the last 12 months.

STOK's SMR Rating (46) in the null industry is somewhat better than the same rating for QTTB (100). This means that STOK’s stock grew somewhat faster than QTTB’s over the last 12 months.

STOK's Price Growth Rating (35) in the null industry is in the same range as QTTB (63). This means that STOK’s stock grew similarly to QTTB’s over the last 12 months.

STOK's P/E Growth Rating (8) in the null industry is significantly better than the same rating for QTTB (100). This means that STOK’s stock grew significantly faster than QTTB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QTTBSTOK
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 7 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 21 days ago
87%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEGG5.470.17
+3.11%
Lottery. com Inc
ROMA3.250.05
+1.56%
Roma Green Finance Limited
VALE10.830.16
+1.50%
Vale SA
UVSP30.72-0.04
-0.13%
Univest Financial Corp
ASB25.92-0.33
-1.26%
Associated Banc-Corp

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been loosely correlated with CLRB. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if QTTB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
-6.22%
CLRB - QTTB
66%
Loosely correlated
+1.38%
MESO - QTTB
51%
Loosely correlated
+4.32%
STOK - QTTB
49%
Loosely correlated
-0.26%
ADCT - QTTB
47%
Loosely correlated
-3.32%
ANAB - QTTB
39%
Loosely correlated
-13.85%
More